← back to search

Sofia Paul

CellCentric (United Kingdom) · GB
Area of research
Hematology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research, Histone Deacetylase Inhibitors Research, and Lung Cancer Diagnosis and Treatment.
h-index
14
citations
3,695
works
39
NIH funding
primary concept
Medicine
email

Recent publications

Targeting <i>RARA</i> overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
Blood Advances 2022cited by 34position: middledoi
Belantamab Mafodotin in Combination with Novel Agents in Relapsed/refractory Multiple Myeloma: DREAMM-5 Study Design
Future Oncology 2021cited by 33position: middledoi
A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors
Investigational New Drugs 2013cited by 34position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Brandon E. Kremer · National and Kapodistrian University of Athens1 papers (2021–2021) · 1 papers (2021–2021)Ajay K. Nooka · Emory University1 papers (2021–2021)Katja Weisel · National Institute Of Blood Disease and Bone Marrow Transplantation1 papers (2021–2021)Brian Gadbaw · Novartis (Switzerland)1 papers (2013–2013)H. Miles Prince · Melbourne Health1 papers (2013–2013)Niels W.C.J. van de Donk · National Cancer Center1 papers (2021–2021)Joachim Beck · Johannes Gutenberg University Mainz1 papers (2013–2013)Natalie S. Callander · University of Wisconsin Carbone Cancer Center1 papers (2021–2021)Paul G. Richardson · Harvard University1 papers (2021–2021) · 1 papers (2013–2013)Monique C. Minnema · University of Applied Sciences Utrecht1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Margaret M. Woo · Novartis (Switzerland)1 papers (2013–2013)Paula Rodríguez‐Otero · Clinica Universidad de Navarra1 papers (2021–2021)Suzanne Trudel · University of Toronto1 papers (2021–2021)